🇺🇸 IDEAYA Biosciences, Inc.IDYA
Get IDEAYA Biosciences, Inc. filings on Telegram the moment they are published.
Follow IDEAYA Biosciences, Inc. on TelegramOne tap starts your 30-day free trial. No card needed.
Subject: 8-K Items 2.02, 9.01
Overview: Reports Q3 2026 financial results, a darovasertib NDA submission, and the closure of the Phase 3 OptimUM-010 trial to reallocate $100-125 million.
Source: SEC EDGAR · Original filing
Get filings like this in Telegram the moment they are published — for the companies you follow.
Start 30-day trial About Finterest